Literature DB >> 19261981

Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging.

O Vakhrusheva1, D Braeuer, Z Liu, T Braun, E Bober.   

Abstract

Mammalian sirtuins, Sirt1-Sirt7, are recently discovered regulatory proteins, which play decisive roles in cellular metabolism, stress resistance, and proliferation. Sirtuins are homologs of the founder member of the sirtuin family, the yeast Sir2. Sir2 encodes a NAD(+)-dependent histone deacetylase and its overexpression extends the lifespan through silencing of specific chromatin regions. Lifespan extension by Sir2 homologs was also demonstrated in more complex species such as C. elegans and D. melanogaster. A longevity function has been also postulated for mammalian sirtuins, however definitive proof is still lacking. Here, we have investigated the role of the mouse Sirt7 in the control of cellular growth and proliferation. Using Sirt7 knockout and overexpressing cells we demonstrate an anti-proliferative role of Sirt7. We also show that Sirt7 expression inversely correlates with the tumorigenic potential of several murine cell lines. Considering the known role of Sirt7 as an activator of rDNA transcription we propose that Sirt7 may enable cells to sustain critical metabolic functions by inhibiting cell growth even under severe stress conditions. We conclude, that these Sirt7 functions may improve tissue integrity in aged animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19261981

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  42 in total

1.  Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

Authors:  Yuan-Chin Tsai; Todd M Greco; Apaporn Boonmee; Yana Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2011-12-05       Impact factor: 5.911

Review 2.  Sirtuin activators and inhibitors.

Authors:  José M Villalba; Francisco J Alcaín
Journal:  Biofactors       Date:  2012-06-25       Impact factor: 6.113

3.  Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Authors:  Jia Yu; Bo Qin; Fengying Wu; Sisi Qin; Somaira Nowsheen; Shan Shan; Jacqueline Zayas; Huadong Pei; Zhenkun Lou; Liewei Wang
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

4.  Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

Authors:  Yuan-Chin Tsai; Todd M Greco; Apaporn Boonmee; Yana Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2012-05       Impact factor: 5.911

Review 5.  Calorie restriction and the exercise of chromatin.

Authors:  Alejandro Vaquero; Danny Reinberg
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

Review 6.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

Review 7.  The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

Review 8.  NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.

Authors:  Hassina Massudi; Ross Grant; Gilles J Guillemin; Nady Braidy
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 9.  Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors.

Authors:  Jianjun Bao; Michael N Sack
Journal:  Cell Mol Life Sci       Date:  2010-08-03       Impact factor: 9.261

Review 10.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.